This study examines the hypothesis that the fluctuating clinical on-off phenomenon accompanying L-DOPA therapy for Parkinson's disease may be due to alterations in the plasma concentrations of the drug. This protocol will examine this hypothesis by appropriate clinical studies.
Showing the most recent 10 out of 336 publications